OAS2 Antikörper (AA 357-371)
Kurzübersicht für OAS2 Antikörper (AA 357-371) (ABIN1782147)
Target
Alle OAS2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- AA 357-371
-
Verwendungszweck
- OAS2 (aa357-371)
-
Sequenz
- QPNKCFLEQI DSAVN
-
Spezifität
- This antibody is expected to recognize reported isoform 1 (NP_058197.2) and isoform 2 (NP_002526.2).
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Immunohistochemistry: Paraffin embedded Human Breast. Recommended concentration: 5 μg/mL.
Western Blot: Approx 70 kDa band observed in lysates of cell lines Daudi, Jurkat and K562 (calculated MW of 78.8 kDa according to NP_002526.2). The observed molecular weight corresponds to earlier findings in literature with different antibodies (Lin et al
Peptide ELISA: antibody detection limit dilution 1:128000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- OAS2 (2'-5'-Oligoadenylate Synthetase 2, 69/71kDa (OAS2))
-
Andere Bezeichnung
- OAS2
-
Hintergrund
- OAS2, 2'-5'-oligoadenylate synthetase 2, 69/71 kDa, (2'-5')oligo(A) synthetase 2, 2'-5'-oligoadenylate synthase 2, 2-5A synthase 2, p69 OAS / p71 OAS
-
Molekulargewicht
- Expected molecular weight 70 kDa
-
Gen-ID
- 4939
-
NCBI Accession
- NP_058197, NP_002526
-
Pathways
- Hepatitis C
Target
-